Histological findings to five years after early conversion of kidney transplant patients from cyclosporine to everolimus: an analysis from the randomized ZEUS study

BACKGROUND: Conversion from calcineurin inhibitor (CNI) therapy to everolimus within 6 months after kidney transplantation improves long-term graft function but can increase the risk of mild biopsy-proven acute cellular rejection (BPAR). We performed a post-hoc analysis of histological data from a r...

Descripción completa

Detalles Bibliográficos
Autores principales: Eisenberger, Ute, Budde, Klemens, Lehner, Frank, Sommerer, Claudia, Reinke, Petra, Witzke, Oliver, Wüthrich, Rudolf P., Stahl, Rolf, Heller, Katharina, Suwelack, Barbara, Mühlfeld, Anja, Hauser, Ingeborg A., Nadalin, Silvio, Porstner, Martina, Arns, Wolfgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6025714/
https://www.ncbi.nlm.nih.gov/pubmed/29954336
http://dx.doi.org/10.1186/s12882-018-0950-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6025714/
https://www.ncbi.nlm.nih.gov/pubmed/29954336
http://dx.doi.org/10.1186/s12882-018-0950-1

Ejemplares similares